Search

Omnicell Inc

Открыт

СекторЗдравоохранение

36.23 -17.73

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

34.71

Макс.

44.25

Ключевые показатели

By Trading Economics

Доход

13M

11M

Продажи

-4.1M

310M

P/E

Средняя по отрасли

94.296

64.641

Прибыль на акцию

0.55

Рентабельность продаж

3.665

Сотрудники

3,525

EBITDA

15M

35M

Рекомендации

By TipRanks

Рекомендации

Активная покупка

Прогноз на 12 месяцев

+48.96% upside

Дивиденды

By Acuity

Следующий отчет о доходах

30 июл. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

176M

1.9B

Предыдущая цена открытия

53.96

Предыдущая цена закрытия

36.23

Новостные настроения

By Acuity

40%

60%

120 / 340 Рейтинг в Healthcare

Omnicell Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

29 июл. 2026 г., 18:26 UTC

News

Omnicell Inc shares are higher as analysts maintain a positive outlook ahead of Thursday's Q2 earnings announcement, following a strong prior quarter with $309.9 million in revenue.

28 июл. 2026 г., 20:51 UTC

Omnicell Inc shares are lower in after-market hours. The decline comes amid no specific news and follows three sessions of higher closes.

27 июл. 2026 г., 19:46 UTC

Omnicell Inc shares are higher today, supported by falling crude oil prices and easing geopolitical tensions following U.S. diplomatic efforts with Iran.

24 июл. 2026 г., 20:13 UTC

Omnicell Inc shares are lower in after-market hours. No specific company news was identified to explain the decline amid recent market volatility.

22 июл. 2026 г., 18:46 UTC

News

Omnicell Inc is trading lower amid negative sentiment and concerns over financial performance. The stock's current price is $41.95.

21 июл. 2026 г., 19:51 UTC

Omnicell Inc's shares are lower during Tuesday's session, reversing from a recent trend of higher daily closes. No specific news was identified for the decline.

20 июл. 2026 г., 19:36 UTC

News

Omnicell Inc shares are lower amid a report suggesting the stock is one to avoid, citing modest revenue growth and declining earnings per share. Current valuation is $45.39.

Сравнение c конкурентами

Изменение цены

Omnicell Inc Прогноз

Целевая цена

By TipRanks

48.96% рост

Прогноз на 12 месяцев

Средняя 61.67 USD  48.96%

Максимум 70 USD

Минимум 55 USD

Основано на мнении 4 аналитиков Wall Street, спрогнозировавших целевые цены для Omnicell Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

4 ratings

4

Покупка

0

Удержание

0

Продажа

Настроения

By Acuity

120 / 340Рейтинг в Здравоохранение

Новостные настроения

Свидетельства восходящего тренда

Волатильность

Ниже среднего

Объем новостей (RCV)

Ниже среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
help-icon Live chat